| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/07/2002 | CN1088583C Stable freeze-dried formulation comprising protein and assay kit |
| 08/07/2002 | CN1088581C Aerosol formulations of peptides and proteins |
| 08/06/2002 | US6429313 Growth hormone secretagogues useful for treatment/prevention of osteoporosis |
| 08/06/2002 | US6429308 Antisense oligonucleotide hybridizes with nucleic acid encoding cxcr4 protein to inhibit gene expression |
| 08/06/2002 | US6429306 Library screening; restriction mapping, cloning, genetic engineering, gene expression; probes for diagnostic kits |
| 08/06/2002 | US6429303 Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same |
| 08/06/2002 | US6429296 Complex of human growth hormone and zinc and use |
| 08/06/2002 | US6429295 Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 08/06/2002 | US6429291 Hyaluronan receptor protein |
| 08/06/2002 | US6429290 Modulation of body weight; diagnosis; dietetics; gene expression; drug screening |
| 08/06/2002 | US6429289 Class BI and CI scavenger receptors |
| 08/06/2002 | US6429288 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds |
| 08/06/2002 | US6429287 Tumor rejection antigens; cancer diagnosis; activators of cytolysis |
| 08/06/2002 | US6429230 Treating chronic uremic patients undergoing periodical dialysis |
| 08/06/2002 | US6429227 Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders |
| 08/06/2002 | US6429208 Administering 2',5'-dideoxyadenosine to inhibit protein kinase a/cyclic adenosine monophosphate pathway; reverses effects of hiv infection; allows for lymphocyte proliferation |
| 08/06/2002 | US6429197 Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain |
| 08/06/2002 | US6429196 Treatment of balance impairments |
| 08/06/2002 | US6429195 Aqueous prolonged release formulation |
| 08/06/2002 | US6429194 Mucin containing ophthalmic preparation |
| 08/06/2002 | US6429193 Elution and purification of gingival fibroblast chemotactic factor (cctf) from bovine source; used to accelerate adhesion of new connective tissue between tooth and gum after periodontal surgery |
| 08/06/2002 | US6429192 Separating mannan-binding lectin (mbl) by affinity chromatography on non-conjugated cross-linked polysaccharide matrix and performing a validated virus reduction step |
| 08/06/2002 | US6429191 Treatment of hearing impairments |
| 08/06/2002 | US6429189 Cytotoxin (non-neurotoxin) for the treatment of human headache disorders and inflammatory diseases |
| 08/06/2002 | US6429188 Vasoactive intestinal peptide and peptide activating hypofissiary adenylate cyclase; inhibiting production of tumor necrosis factor and interleukin 6; amino acid seq id no:1, 2 and 3 |
| 08/06/2002 | US6429187 Method of diagnosing and treating gliomas |
| 08/06/2002 | US6429186 Ligand antagonists for treatment of breast cancer |
| 08/06/2002 | US6429010 Treating schizophrenia |
| 08/06/2002 | US6429009 Recombinant retroviral expression vector comprising a replication-defective, nonproducing, interfering, modified human immunodeficiency virus type 1 (hiv-1) f12 proviral genome |
| 08/06/2002 | US6428990 Conversion of dihomo-gamma-linolenic acid to arachidonic acid and 20:4n-3 to eicosapentaenoic acid by host cell transformed to express human delta5-desaturase enzyme |
| 08/06/2002 | US6428985 Murine or human il-10 amino acid sequence, and wherein isoleucine at position 87 is replaced by one amino acid other than leucine or valine, converting it from an immunostimulant to an immunosuppresant |
| 08/06/2002 | US6428983 Histone deacetylase as target for antiprotozoal agents |
| 08/06/2002 | US6428982 Polynucleotides encoding mouse urotensin-II Receptor (UTB-R) |
| 08/06/2002 | US6428979 Receptor protein for human B cell stimulatory factor-2 |
| 08/06/2002 | US6428970 Chemokine inhibition of immunodeficiency virus |
| 08/06/2002 | US6428968 Combined therapy with a chemotherapeutic agent and an oncolytic virus for killing tumor cells in a subject |
| 08/06/2002 | US6428966 Growth differentiation factor, lefty-1 |
| 08/06/2002 | US6428954 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| 08/06/2002 | US6428815 Multifluid atomization of a dispersed system of a biologically active agent and a solvent to produce droplets; freezing the droplets; lyophilizing the frozen droplets obtain microstructures capable of being further fragmented |
| 08/06/2002 | US6428814 Stabilizers prevent aggregation of nanoparticles and increase bioadhesion to substrates such as an insect, teeth, bone, nails, chitin, feathers, scales, mucous, skin, hair, and/or plant tissue |
| 08/06/2002 | US6428812 Process for producing granules containing angiotensin-converting enzyme inhibiting peptides |
| 08/06/2002 | US6428790 Using viricidal polypeptides on solid supports for prophylaxis of human t-cell leukemia/lymphoma virus; antibodies |
| 08/06/2002 | US6428788 Preferential drug delivery to tumors having interleukin receptors; side effect reduction |
| 08/06/2002 | US6428786 Composition and method for lactose hydrolysis |
| 08/06/2002 | US6428785 Local administration of therapeutically effective concentration of collagenase for therapy of prostate cancer in mammal |
| 08/06/2002 | US6428784 Vaginal suppository for treating group B Streptococcus infection |
| 08/06/2002 | US6428781 Composition of an endogenous insulin-like growth factor-II derivative |
| 08/06/2002 | US6428780 Modified amino acid |
| 08/06/2002 | US6428771 Method for drug delivery to the pulmonary system |
| 08/06/2002 | US6427681 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
| 08/06/2002 | CA2130832C Virus-targeted biocatalysts |
| 08/06/2002 | CA2122714C Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
| 08/06/2002 | CA1341380C Process for the preparation of n-alkylated amino acids and their esters, use in the synthesis of carboxyalkyl dipeptides |
| 08/05/2002 | WO2003079746A2 A novel human g-protein coupled receptor, hgprbmy14, related to the orphan gpcr, gpr73 |
| 08/05/2002 | CA2440930A1 A novel human g-protein coupled receptor, hgprbmy14, related to the orphan gpcr, gpr73 |
| 08/02/2002 | WO2001055207A1 Nucleic acids, proteins, and antibodies |
| 08/02/2002 | CA2395738A1 Nucleic acids, proteins, and antibodies |
| 08/01/2002 | WO2002060163A2 Methods for increasing bone formation and enhancing bone accretion |
| 08/01/2002 | WO2002059604A2 Diagnosis and treatment of multiple sclerosis |
| 08/01/2002 | WO2002059369A2 Compositions and methods for the treatment of diseases related to faulty cholesterol regulation |
| 08/01/2002 | WO2002059356A2 Method for screening compounds for activity in treating an osteoclast related bone disease |
| 08/01/2002 | WO2002059350A2 Use of sialyltransferases for diagnosing and treating tumorous diseases |
| 08/01/2002 | WO2002059346A2 Constitutively active, hypersensitive, and nonfunctional receptors as novel therapeutic agents |
| 08/01/2002 | WO2002059337A1 Anti-apoptopic gene scc-s2 and diagnostic and therapeutic uses thereof |
| 08/01/2002 | WO2002059327A2 Sulfatases and methods of use thereof |
| 08/01/2002 | WO2002059323A2 Aminoacyl trna synthetases |
| 08/01/2002 | WO2002059313A2 G-protein coupled receptors and nucleic acids encoding same |
| 08/01/2002 | WO2002059312A2 Cell adhesion proteins |
| 08/01/2002 | WO2002059311A2 Colon cancer marker |
| 08/01/2002 | WO2002059310A2 Polynucleotides encoding cellular transporters and methods of use thereof |
| 08/01/2002 | WO2002059308A2 Method of diagnosing and treating cartilage disorders |
| 08/01/2002 | WO2002059304A1 Novel g protein-coupled receptor protein and dna thereof |
| 08/01/2002 | WO2002059302A2 Regulation of human serotonin-like g protein-coupled receptor |
| 08/01/2002 | WO2002059301A1 Chemokines |
| 08/01/2002 | WO2002059300A2 Double-stranded rna-mediated gene suppression |
| 08/01/2002 | WO2002059295A1 Novel serine protease mp493 |
| 08/01/2002 | WO2002059291A2 Biological organism for preparing pharmaceutical compositions for treating mammals |
| 08/01/2002 | WO2002059289A1 Use of microbial hyaluronate lyase for softening connective tissue |
| 08/01/2002 | WO2002059286A2 Adenylate cyclases |
| 08/01/2002 | WO2002059283A2 Nucleic acid modification enzymes |
| 08/01/2002 | WO2002059268A2 Factor ixa: factor viiia interaction and methods therefor |
| 08/01/2002 | WO2002059267A2 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | WO2002059264A2 Specific human antibodies for selective cancer therapy |
| 08/01/2002 | WO2002059258A2 Chimeric proteins for prevention and treatment of hiv infection |
| 08/01/2002 | WO2002059256A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/01/2002 | WO2002059153A2 Anticoagulants and their uses |
| 08/01/2002 | WO2002059149A2 Pro-apoptotic proteins and dna molecules encoding them |
| 08/01/2002 | WO2002059147A2 Activatable cytolytic or drug delivery peptides and uses thereof |
| 08/01/2002 | WO2002059146A2 Peptides having affinity for the gp120 viral protein and use thereof |
| 08/01/2002 | WO2002059145A1 Methods for preparing purified lipopeptides |
| 08/01/2002 | WO2002059143A2 Therapeutic peptides for demyelinating conditions |
| 08/01/2002 | WO2002059141A1 Peptide derivatives |
| 08/01/2002 | WO2002059140A2 Ikaros rgulatory elements and uses thereof |
| 08/01/2002 | WO2002059131A1 Formulation of boronic acid compounds |
| 08/01/2002 | WO2002059130A1 Formulation of boronic acid compounds |
| 08/01/2002 | WO2002059117A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 08/01/2002 | WO2002059108A1 Melanocortin receptor agonists |
| 08/01/2002 | WO2002059095A1 Melanocortin receptor agonists |
| 08/01/2002 | WO2002059065A2 Oligo or polyalkylene glycol-coupled thrombin inhibitors |
| 08/01/2002 | WO2002058789A1 Ocular iontophoretic device and method of use |